Skip to main content

SeaStar Medical Holding Corp

For the period ended Dec 31, 2024. Filed Mar 27, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 27, 2025

ICU$1.90-3.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Power of Attorney (included on the signature page hereto)

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned constitutes and appoints Eric Schlorff his or her true and lawful attorney-in-fact and agent, with full power of substitution and revocation, for him or her and in his or her name, place and stead, in any and all capacities, to execute any or all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this report has been signed below by the following persons in the capacities and on the dates indicated.

NameTitleDate
/s/ Eric SchlorffEric SchlorffChief Executive Officer and Director(Principal Executive Officer)March 27, 2025
/s/ David GreenDavid GreenChief Financial Officer(Principal Financial and Accounting Officer)March 27, 2025
/s/ Rick BarnettRick BarnettChairman of the Board of DirectorsMarch 27, 2025
/s/ Jennifer A. BairdJennifer A. BairdDirectorMarch 27, 2025
/s/ John NeumanJohn NeumanDirectorMarch 27, 2025
/s/ Kenneth Van HeelKenneth Van HeelDirectorMarch 27, 2025
/s/ Bernadette N. VincentBernadette N. VincentDirectorMarch 27, 2025
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.